ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,349Medicare Part D Prescriptions Filled, Including Refills

Rank: 16 out of 247

$600K Total Retail Price of All Prescriptions

Rank: 25 out of 247

502 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
65% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maine
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 502 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

15% of this provider’s 502 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

2% of this provider’s 7,763 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$64 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maine
OMEPRAZOLE 349 276 1 4
LEVOTHYROXINE SODIUM 347 301 2 3
METOPROLOL TARTRATE 280 240 3 7
AMLODIPINE BESYLATE 241 217 4 6
HYDROCODONE-ACETAMINOPHEN 224 136 S3 5 11
FUROSEMIDE 221 199 6 5
LOVASTATIN 213 190 7 22
ATORVASTATIN CALCIUM 212 179 8 8
TRAMADOL HCL 210 160 9 25
LISINOPRIL 158 152 10 2
SIMVASTATIN 154 130 11 1
DONEPEZIL HCL 137 137 12 35
PAROXETINE HCL 127 112 13 45
SERTRALINE HCL 122 101 14 16
GABAPENTIN 112 80 15 17
PREDNISONE 110 107 16 21
HYDROCHLOROTHIAZIDE 105 97 17 9
TRIAMTERENE-HCTZ 104 104 18 67
RANITIDINE HCL 103 92 19 34
NORTRIPTYLINE HCL 101 64 20 152
ALLOPURINOL 99 96 21 33
PROAIR HFA 97 94 22 29
TRAZODONE HCL 93 83 23 28
SUCRALFATE 82 79 24 131
WARFARIN SODIUM 81 79 25 13
NEXIUM 80 61 26 42
PROMETHAZINE HCL 79 68 R 27 187
METOPROLOL SUCCINATE 79 74 27 14
CRESTOR 78 76 29 30
PANTOPRAZOLE SODIUM 77 67 30 19
ADVAIR DISKUS 77 55 30 18
BENAZEPRIL HCL 77 70 30 80
CITALOPRAM HBR 76 52 33 20
NAMENDA 75 75 34 47
METFORMIN HCL 74 47 35 12
BENAZEPRIL-HYDROCHLOROTHIAZIDE 72 61 36 197
KLOR-CON M20 72 64 36 44
GLIMEPIRIDE 68 58 38 80
CLOPIDOGREL 68 66 38 70
FLUTICASONE PROPIONATE 67 58 40 37
TRIMETHOPRIM 65 64 41 209
PRAVASTATIN SODIUM 64 64 42 23
ZOLPIDEM TARTRATE 60 48 43 24
ISOSORBIDE MONONITRATE ER 58 55 44 40
TAMSULOSIN HCL 57 47 45 31
SPIRIVA 55 50 46 26
PEN NEEDLE 55 53 46 79
CYCLOBENZAPRINE HCL 55 34 R 46 54
FINASTERIDE 52 52 49 73
BUSPIRONE HCL 51 32 50 230
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 28, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.